GNAQ and uveal melanoma: Gain of function in Gαq and Gα11 leads oncogenic transformation [3, 4] and is particularly prevalent in the development and progression of uveal melanoma, where Gαq and Gα11 share activating mutations and are currently being evaluated for both diagnostic and therapeutic purposes [5–8].